Tenders/[N11532] Tender for Medication for Advanced Gastrointestinal Stromal Tumors

Open🇹🇼TaiwanSupplies

[N11532] Tender for Medication for Advanced Gastrointestinal Stromal Tumors

Auto-translated from Chinese

Original title: [N11532] 治療晚期胃腸道基質瘤藥品招標案

臺北市立聯合醫院

Published: Aug 10, 2026

Updated: Aug 10, 2026

Source: taiwan_pcc

About This Opportunity

This is a supplies contract in the general supplies and health and medical services sectors, with a focus on Hospitals and Pharmaceuticals. Located in Taiwan, Asia, this opportunity is open to firms and consortiums, with an estimated budget of TWD 4.5 million. Proposals must be submitted before August 20, 2026.

Published through Taiwan PCC e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

Taipei City Hospital is conducting a tender for the procurement of medication for treating advanced gastrointestinal stromal tumors (GIST). This tender, reference number N11532, is for goods with an estimated budget of NT$4,458,840. The procurement method is a restricted tender based on public selection or public solicitation, suggesting a need for specialized pharmaceuticals where supplier qualifications and the suitability of the proposed drug are critical evaluation factors. Typical requirements for pharmaceutical tenders include the provision of specific drug formulations, dosages, and packaging, adherence to stringent quality and regulatory standards (e.g., GMP), proof of drug efficacy and safety data, and a reliable supply chain. The hospital is seeking a supplier capable of providing a cost-effective and clinically appropriate treatment option for patients with advanced GIST, ensuring timely availability of the medication.

Data provenance

This notice is sourced from Taiwan PCC e-Procurement and was originally published on August 10, 2026. Last refreshed today. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About 臺北市立聯合醫院

臺北市立聯合醫院 has issued 676 procurement notices on BidsFactory, including 43 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Taiwan. Notices are distributed via Taiwan PCC e-Procurement. Most recent publication: August 7, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Taiwan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Taiwan PCC e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is August 20, 2026. You have 10 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by 臺北市立聯合醫院 in Taiwan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the General Supplies & Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is NT$4,458,840 - NT$4,458,840. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.